Minocycline Hydrochloride NDC 13668-482

NDC codes

FDA NDC Directory

Product NDC (as listed)13668-482Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13668-0482Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
13668-482-01	13668048201	100 CAPSULE in 1 BOTTLE (13668-482-01)Marketed from Apr 2, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Minocycline Hydrochloride
Generic name (nonproprietary): minocycline hydrochloride
Active ingredients: Minocycline hydrochloride — 50 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Torrent Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065062
Marketing start: Apr 2, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Prothrombin Activity (Physiologic effect)Tetracyclines (Chemical structure)
Identifiers: Product ID 13668-482_4ee4f6d7-55da-406d-9a32-de923b01c15cSPL ID 4ee4f6d7-55da-406d-9a32-de923b01c15cSPL set ID 55df55fb-18ec-4e00-9ed0-10bba0da513bRxCUI 197984, 197985, 314108UNII 0020414E5U
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413668048201 followed by a unit qualifier and the quantity

Package 13668-0482-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 2, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Minocycline hydrochloride capsules, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae . Lymphogranuloma venereum caused by Chlamydia trachomatis . Psittacosis (Ornithosis) due to Chlamydophila psittaci . Trachoma caused by Chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis . Nongonococcal urethr…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)